Ingersoll Rand introduces specialist tools designed for compact spaces
Global power tool company, Ingersoll Rand, has announced the release of 35MAX and 15QMAX Ultra-Compact ImpactoolsTM, small yet powerful tools that technicians and operators can use to quickly loosen or tighten a variety of fasteners in confined spaces. The 35MAX and 15QMAX pneumatic impact tools have high power-to-weight ratios, easy-to-operate regulator dials with three power settings, and simple forward and reverse capabilities.
Each tool has three power settings, as well as full maximum reverse torque at all levels, meaning technicians can insert and loosen fasteners on a variety of equipment and vehicles. The power regulator and push-button forward/reverse buttons are located on the back of the tool so that it can be easily operated in confined areas with one hand.
On top of that, the new ergonomic design and unique twin hammer mechanism reduce vibration to give operators better control during use. The 35MAX Ultra-Compact impact tool has a half-inch square drive and 610 Nm of maximum reverse torque. The 15QMAX impact has a three-eighth inch square drive and 520 Nm of maximum reverse torque, along with premiere quiet technology to reduce the amount of noise the tool creates. Rigorous internal testing methods indicate that the lifetime of each Ultra-Compact tool is twice as long as competitive products available today.
Michael Cafferty, Product Manager for Ingersoll Rand, said: “The access points in vehicle frames are getting increasingly confined and common impact tools cannot fit in areas that need servicing. Lightweight yet powerful, Ingersoll Rand Ultra-Compact Impactools help technicians and equipment engineers get the job done right every time.”
Follow @ManufacturingGL and @NellWalkerMG
IMF: Variants Can Still Hurt Manufacturing Recovery
After a year of on-and-off manufacturing in the US, UK, and the eurozone, demand for goods surged early last week. Factories set growth records in April and May, suppliers started to recover, and US crude hit its highest price point since pre-COVID. As vaccination efforts immunise much of the US and UK populations, manufacturers are now able to fully ramp up their supply chains. In fact, GDP growth could approach double-digits by 2022.
Now, the ISM productivity measure has surpassed the 50-point mark that separates industry expansion from contraction. Since U.S. president Biden passed his US$1.9tn stimulus package and the UK purchasing managers index (PMI) increased to 65.6, both sides of the Atlantic are facing a much-welcomed manufacturing recovery.
Lingering Concerns Over COVID
Even as Spain, France, Italy, and Germany race to catch up, and mining companies pushed the FTSE 100 index of list shares to a monthly high of 7,129, some say that UK and US markets still suffer from a lack of confidence in raw material supplies. Yes, the Dow Jones has made up its 19,173-point crash of March 2020, and MSCI’s global stock index is at an all-time high.
Yet manufacturers around the world realise that these wins will be short-lived until pandemic supply chain bottlenecks are solved. If we keep the status quo, consumers will pay the price. In April, inflation in Germany reached 2.4%, and across the EU’s 19 member countries, overall prices have increased at an unusual pace. Some ask: Is this true recovery?
IMF: Current Boom Could Falter
Even as Elon Musk tweeted about chip shortages forcing Tesla to raise its prices, UK mining demand skyrocketed; housing markets lifted; and the pound sterling gained value. The International Monetary Fund (IMF), however, cautioned that manufacturing recovery won’t last long if COVID mutates into forms our vaccinations can’t touch. Kristalina Georgieva, Washington’s IMF director, noted that fewer than 1% of African citizens have been vaccinated: “Worldwide access to vaccines offers the best hope for stopping the coronavirus pandemic, saving lives, and securing a broad-based economic recovery”.
Across the globe, manufacturing companies are keeping a watchful eye on new developments in the spread of COVID. Though US FDA officials don’t think we’ll have to “start at square one” with new vaccines, the March 2021 World Economic Outlook states that “high uncertainty” surrounds the projected 6% global growth. Continued manufacturing success will in large part depend on “the path of the pandemic, the effectiveness of policy support, and the evolution of financial conditions”.
Mathias Cormann, secretary-general of the Organisation for Economic Co-Operation and Development (OECD) concurred—without global immunisation, the estimated economic boom expected by 2025 could go kaput. “We need to...pursue an all-out effort to reach the entire world population”, Australia’s finance minister added. US$50bn to end COVID across the world, they imply, is a small investment to restart our economies.